The immune and metabolic phenotypes of RCC CD8+ TILs were next compared by evaluating protein levels in matched tumors, normal tumor adjacent kidney, and peripheral blood by mass cytometry. The gene discussed is CD8A; the disease is renal cell carcinoma.